Drug Profile
PF 6409577
Alternative Names: PF-06409577; PF-6409577Latest Information Update: 06 Aug 2015
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic nephropathies
Most Recent Events
- 28 Jul 2015 Discontinued - Phase-I for Diabetic nephropathies (In volunteers) in Belgium (PO)
- 27 May 2015 Pfizer resumes enrolment in a phase I trial in Diabetic nephropathies (In volunteers) in Belgium (NCT02286882)
- 24 Apr 2015 Pfizer suspends phase I trial in Diabetic nephropathies (In volunteers) in Belgium (NCT02286882)